Tuesday, 7 September 2021

The 'Vaccine' and the Irish bishops part 3


Your excellency, in your statement you write,


“The development of a vaccine which is safe, effective, and widely available represents the best chance of a return to normal living, for all of us,” This comes right out of Bill Gates’ note book. With all due respect your excellency it is untrue.


Hence the first criterion from Vatican statement is not fulfilled here.


There is a grave responsibility to use alternative treatments. This has not been employed. On the contrary, there is much evidence of Big Pharma companies, main stream media (MSM) and governments aggressively using every avenue mostly immoral to suppress, close down, mock and vilify any and every effort of all those, no matter what their vast medical experience, so that they can not promote or manufacture ethical, safe, effective and cheap alternatives to deal with corona virus. In the Vatican alternative treatment is referenced fourteen times. One could ask how could this have been overlooked? Not easily!

Yes, there are alternatives. One of these is Hydroxychloroquine.(HCQ). There have been numerous studies done by various medical professionals who have come up with very good results especially in the early stages of the virus. Take for instance Uganda; in August 2020, it had only 15 deaths from corona virus. They were using Hydroxychloroquine obviously with great effect. The greatest benefit from this remedy is when it is administered in the earlier stages. WHO told Uganda they were to stop using HCQ. Since then there has been a 1200% increase in deaths in Uganda.

Studies have shown that Hydroxychloroquine has reduced the number of persons from being hospitalized by up to 84% when administered with Zinc and Azithromycin. Source: Science direct. Debi Vinnedge to whom the Vatican statement was addressed following her enquiries has stressed,

“we have morally produced treatments for patients who are already infected, notably Hydroxychloroquine or Plaquenils.”

(plaquenils is another name for Hydroxychlorine) Another doctor, Dr Stella Immanuel, said she has treated over 350 patients at the clinic where she works in Houston Texas, Rehoboth Medical Centre. She stated outside the U.S. Supreme court:

“In the past few months, after taking in over 350 patients, we [Rehoboth Medical Center] have not lost one. Not a diabetic, not somebody with high blood pressure, not somebody with asthma, not an old person. We’ve not lost one patient.” Source: American frontline doctors, Whitecoat summit, outside supreme court Washington D.C. 28/07/2020 But the video of Dr. Immanuel testifying to the effectiveness of hydroxychloroquine was taken down, censored by Twitter, YouTube and Facebook, and denounced by Bill Gates as “outrageous”. It just so “happens” that Bill Gates is developing a COVID-19 vaccine with German biotech company CureVac, Moderna, GlaxoSmithKline.

Dr Harvey Risch of Yale university has written a paper on defending the use of HCQ; he comments:

“I reiterate: we are considering the evidence for early treatment of high-risk outpatients to prevent hospitalization and mortality. That is it. Treatment starting in the first five days or so after the onset of symptoms. Treatment of older patients or patients with chronic conditions such as diabetes, obesity, heart diseases, lung diseases, kidney diseases, immune-system diseases, survivors of cancer etc. These are the people most likely to die from Covid, and they are the people most needing protection. I have sought to obtain reports of every study of every medication pertaining to early treatment of high-risk outpatients. I monitor the literature daily. And what I have found is actually quite remarkable. What I have observed is that while there have been positive reports about a number of drugs, every study of outpatient use of one drug, hydroxychloroquine, with or without accompanying agents, has shown substantial benefit in reducing risks of hospitalization and mortality.

So what did I find about hydroxychloroquine in early use among high-risk outpatients? The first thing is that hydroxychloroquine is exceedingly safe. Common sense tells us this, that a medication safely used for 65 years by hundreds of millions of people in tens of billions of doses worldwide, prescribed without routine screening EKGs, given to adults, children, pregnant women and nursing mothers, must be safe when used in the initial viral-replication phase of an illness that is similar at that point to colds or flu. In fact, a study by researchers at the University of Oxford showed that in 14 large international medical-records databases of older rheumatoid arthritis patients, no significant differences were seen in all-cause mortality for patients who did or did not use hydroxychloroquine. The Oxford investigators also looked at cardiac arrhythmias and found no increase for hydroxychloroquine users. This was in more than 900,000 hydroxychloroquine users. This is examined at length in my paper in the American Journal of Epidemiology in May…

About studies of hydroxychloroquine early use in high-risk outpatients, every one of them, and there are now seven studies, has shown significant benefit: 636 outpatients in São Paulo, Brazil; 199 clinic patients in Marseille, France; 717 patients across a large HMO network in Brazil; 226 nursing-home patients in Marseille; 1,247 outpatients in New Jersey; 100 long-term care institution patients in Andorra (between France and Spain); and 7,892 patients across Saudi Arabia. All these studies pertain to the early treatment of high-risk outpatients—and all showed about 50 percent or greater reductions in hospitalization or death. The Saudi study was a national study and showed 5-fold reduction in mortality for hydroxychloroquine plus zinc vs zinc alone. Not a single fatal cardiac arrhythmia was reported among these thousands of patients attributable to the hydroxychloroquine.

We have spent the last six months with formal government policies and warnings against early outpatient treatment, with large government investments in vaccines and expensive new treatments yet to be proven and almost no support of inexpensive but useful medications, and a quarter of a million Americans have died from this mismanaged approach. Even with newly promising vaccines, we have almost no information about how they will perform in older and high-risk patients, in whom respiratory virus vaccines are known to have weak efficacy; it will be a number of months before they become widely available; and we don’t know how long vaccine immunity will last, or even if the vaccines will work for the newly increasing mutant strains of the virus. As I have said on many occasions, the evidence for benefit of hydroxychloroquine used early in high-risk outpatients is extremely strong, and the evidence against harm is also equally strong. This body of evidence dramatically outweighs the risk/benefit evidence for remdesivir, monoclonal antibodies or the difficult to use bamlanivimab that the FDA has approved for emergency use authorizations while denying the emergency use authorization for hydroxychloroquine. This egregious double standard for hydroxychloroquine needs to be overturned immediately and its emergency use authorization application approved.”

Statement of Harvey A. Risch, MD, PhD Professor of Epidemiology, Yale School of Public Health to the U.S. house senate hearing.

Dr. Lisa Koche, MD, a medical specialist affiliated with St Joseph’s hospital Florida is another doctor who advocates the use of HCQ. She is triple board certified with 8000 patients under her care desiring to give to her patients. She understands over this medication that it is perfectly safe which has been used for the last sixty five years with no dangerous side effects and is now prevented from giving it to her patients because of the banning of HCQ. She recommends that this medication be administered early on, a 200mg dose being given as a preventative against Sars-Cov-2.

Dr Zev Zelenko has been nominated for the Nobel medical prize for his work on Sars-CoV-2 successfully treated 350 patients with HCQ with 100% outcome. He has a common sense approach and he enumerates numerous other treatments for Sars-CoV-2, such as treatment regimens like Hydroxychloroquine, Zinc and Azithromycin. He has said that there are also other approaches such as Ivermectin, steroids, blood thinners that can be utilized against the virus. See: Science Direct, “Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?”

Dr Brian Procter, a board certified physician, has treated over 350 patients within 3 months. He has had a 100% success with his regime of treating patients with HCQ. When treated early there has been no ventilators, no hospitalizations, no ER visits, no cardiac arrests, no side effects,

He proffered the following;

“ if we treat COVID-19 just like anything else we treat (ie, the flu, pneumonia, a sinus infection, hypertension, and diabetes) early and aggressively with a regimen that costs $50 out of pocket or less with 100% success (which is a far better stat than treating all those other conditions), then why is the country shut down and doing social distancing? This political sham must stop.

The American people deserve to know they can go to their regular doctor and get treated early with a regimen that is completely safe and extremely effective, and they do not need to worry about ending up in the hospital and dying. The public is UNAWARE of this, please educate them with the truth. The country needs to return to normal NOW. This is the REAL story. Please feel free to contact me with questions. My heart goes out to all those who have needlessly suffered and continue to suffer during this sham crisis and a disease that is extremely treatable if treated EARLY!!!”

Source, Dr Eowyn, Fellowship of Minds

The number of medical doctors that accept this substance as a safe and effective medicament are too numerous to list here.

No comments:

Post a Comment